Combined Targeting of mTORC1 and mTORC2 Synergistically Inhibits Proliferation of Hepatocellular Carcinoma Cells: Effects of Everolimus and Ku0063794

被引：0
|
作者：
Kim, Say-June
Choi, Ho-Joong
Kim, Dong-Goo
机构：
[1] Catholic Univ Korea, Dept Surg, Daejeon St Marys Hosp, Taejon, South Korea
[2] Catholic Univ Korea, Buchen St Marys Hosp, Dept Surg, Puchon, South Korea
[3] Catholic Univ Korea, Seoul St Marys Hosp, Dept Surg, Seoul, South Korea
来源：
LIVER TRANSPLANTATION | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-268
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [21] Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors
    Altman, Jessica K.
    Sassano, Antonella
    Kaur, Surinder
    Glaser, Heather
    Kroczynska, Barbara
    Redig, Amanda J.
    Russo, Suzanne
    Barr, Sharon
    Platanias, Leonidas C.
    CLINICAL CANCER RESEARCH, 2011, 17 (13) : 4378 - 4388
  • [22] A20 interacts with mTORC2 to inhibit the mTORC2/Akt/Rac1 signaling axis in hepatocellular carcinoma cells
    Wang, Xinyu
    Xiao, Ying
    Dong, Yanlei
    Wang, Zhida
    Yi, Jing
    Wang, Jianing
    Wang, Xiaoyan
    Zhou, Huaiyu
    Zhang, Lining
    Shi, Yongyu
    CANCER GENE THERAPY, 2023, 30 (03) : 424 - 436
  • [23] mTORC2, but not mTORC1, regulates chemotherapy resistance in A549 lung cancer cells
    Chawsheen, M.
    Dash, P. R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S130 - S130
  • [24] Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
    Nicole Grabinski
    Florian Ewald
    Bianca T Hofmann
    Katharina Staufer
    Udo Schumacher
    Björn Nashan
    Manfred Jücker
    Molecular Cancer, 11
  • [25] Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
    Grabinski, Nicole
    Ewald, Florian
    Hofmann, Bianca T.
    Staufer, Katharina
    Schumacher, Udo
    Nashan, Bjoern
    Juecker, Manfred
    MOLECULAR CANCER, 2012, 11
  • [26] Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
    Ewald, Florian
    Grabinski, Nicole
    Staufer, Katharina
    Hofmann, Bianca
    Juecker, Manfred
    Nashan, Bjoern
    HEPATOLOGY, 2012, 56 : 624A - 625A
  • [27] mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells
    Le Bacquer, Olivier
    Queniat, Gurvan
    Gmyr, Valery
    Kerr-Conte, Julie
    Lefebvre, Bruno
    Pattou, Francois
    JOURNAL OF ENDOCRINOLOGY, 2013, 216 (01) : 21 - 29
  • [28] mTORC1 and mTORC2 Expression Levels in Oral Squamous Cell Carcinoma: An Immunohistochemical and Clinicopathological Study
    Kawasaki, Goro
    Naruse, Tomofumi
    Furukawa, Kohei
    Umeda, Masahiro
    ANTICANCER RESEARCH, 2018, 38 (03) : 1623 - 1628
  • [29] Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivo
    Pan, Xiao-dong
    Gu, Dong-hua
    Mao, Jia-Hui
    Zhu, Hua
    Chen, Xinfeng
    Zheng, Bing
    Shan, Yuxi
    PLOS ONE, 2017, 12 (03):
  • [30] RICTOR Amplification Promotes NSCLC Cell Proliferation through Formation and Activation of mTORC2 at the Expense of mTORC1
    Kim, Laura C.
    Rhee, Christopher H.
    Chen, Jin
    MOLECULAR CANCER RESEARCH, 2020, 18 (11) : 1675 - 1684
12345